DNA Aptamer Selected against Pancreatic Ductal Adenocarcinoma for in vivo Imaging and Clinical Tissue Recognition
暂无分享,去创建一个
Weihong Tan | Ting Fu | Qiaoling Liu | Zilong Zhao | W. Tan | Zilong Zhao | Ting Fu | C. Yang | Mao Ye | Xiaoqiu Wu | Huarong Bai | Mao Ye | I-Ting Teng | Carole Champanhac | Xiaoxiao Hu | Qiaoling Liu | Xiaoxiao Hu | I-ting Teng | Xiaoqiu Wu | Chao Yang | Huarong Bai | C. Champanhac
[1] L. Gold,et al. A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[2] Ying-Fon Chang,et al. Tumor targeting by an aptamer. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] M. Saif,et al. Screening for early pancreatic ductal adenocarcinoma: an urgent call! , 2009, JOP : Journal of the pancreas.
[4] J. Winter,et al. Biomarkers in Pancreatic Cancer: Diagnostic, Prognostic, and Predictive , 2012, Cancer journal.
[5] L. Gold,et al. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.
[6] Weihong Tan,et al. Cell-specific aptamer probes for membrane protein elucidation in cancer cells. , 2008, Journal of proteome research.
[7] D. Shangguan,et al. Aptamers evolved from live cells as effective molecular probes for cancer study , 2006, Proceedings of the National Academy of Sciences.
[8] E. Fishman,et al. Recent progress in pancreatic cancer , 2013, CA: a cancer journal for clinicians.
[9] S. Jayasena. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. , 1999, Clinical chemistry.
[10] H. Kocher,et al. Pancreatic Cancer , 2019, Methods in Molecular Biology.
[11] R. DePinho,et al. Pancreatic cancer biology and genetics , 2002, Nature Reviews Cancer.
[12] Xiaohong Fang,et al. Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach. , 2010, Accounts of chemical research.
[13] Weihong Tan,et al. Identification of liver cancer-specific aptamers using whole live cells. , 2008, Analytical chemistry.
[14] Weihong Tan,et al. Aptamers from cell-based selection for bioanalytical applications. , 2013, Chemical reviews.
[15] Kemin Wang,et al. Activatable aptamer probe for contrast-enhanced in vivo cancer imaging based on cell membrane protein-triggered conformation alteration , 2011, Proceedings of the National Academy of Sciences.
[16] Weihong Tan,et al. Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics , 2013, Proceedings of the National Academy of Sciences.
[17] D. Shangguan,et al. Development of DNA aptamers using Cell-SELEX , 2010, Nature Protocols.
[18] Xiaohong Fang,et al. Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells. , 2009, The Analyst.
[19] J. Szostak,et al. In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.
[20] Weian Zhao,et al. Bioinspired multivalent DNA network for capture and release of cells , 2012, Proceedings of the National Academy of Sciences.
[21] R. Stoltenburg,et al. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands. , 2007, Biomolecular engineering.
[22] Xiaochun Xu,et al. Specific Capture and Release of Circulating Tumor Cells Using Aptamer‐Modified Nanosubstrates , 2013, Advanced materials.
[23] Dario Neri,et al. Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform , 1997, Nature Biotechnology.
[24] Weihong Tan,et al. Aptamer-enabled efficient isolation of cancer cells from whole blood using a microfluidic device. , 2012, Analytical chemistry.
[25] H. Bergh,et al. Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice. , 1994, Cancer research.